AIMCA
ATRA icon

Alberta Investment Management Corp (AIMCo)’s Atara Biotherapeutics ATRA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,737
Closed -$1.2M – 1088
2022
Q3 		$1.2M Hold
12,737
– – 0.01% 857
2022
Q2 		$2.48M Sell
12,737
-2,580
-17% -$421K 0.02% 663
2022
Q1 		$3.56M Buy
15,317
+4,072
+36% +$1.3M 0.02% 636
2021
Q4 		$4.43M Sell
11,245
-12,688
-53% -$5.34M 0.03% 465
2021
Q3 		$10.7M Sell
23,933
-10,652
-31% -$3.82M 0.09% 248
2021
Q2 		$13.4M Sell
34,585
-6,596
-16% -$2.35M 0.11% 200
2021
Q1 		$14.8M Buy
41,181
+16,720
+68% +$7.39M 0.13% 169
2020
Q4 		$12M Sell
24,461
-5,332
-18% -$2.46M 0.11% 225
2020
Q3 		$9.65M Sell
29,793
-568
-2% -$193K 0.1% 240
2020
Q2 		$11.1M Buy
30,361
+8,832
+41% +$2.23M 0.13% 196
2020
Q1 		$4.58M Hold
21,529
– – 0.08% 275
2019
Q4 		$8.87M Buy
21,529
+7,048
+49% +$2.43M 0.07% 254
2019
Q3 		$5.11M Buy
14,481
+4,124
+40% +$1.54M 0.05% 331
2019
Q2 		$5.21M Buy
10,357
+4,536
+78% +$3.2M 0.05% 329
2019
Q1 		$5.79M Buy
5,821
+1,444
+33% +$1.34M 0.05% 292
2018
Q4 		$3.8M Buy
4,377
+3,044
+228% +$2.83M 0.04% 325
2018
Q3 		$1.38M Sell
1,333
-468
-26% -$458K 0.01% 553
2018
Q2 		$1.66M Buy
1,801
+520
+41% +$559K 0.01% 488
2018
Q1 		$1.25M Sell
1,281
-292
-19% -$266K 0.01% 522
2017
Q4 		$712K Hold
1,573
– – 0.01% 600
2017
Q3 		$651K Hold
1,573
– – 0.01% 617
2017
Q2 		$551K Buy
+1,573
New +$606K 0.01% 633

Other funds holding ATRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ATRA Position: Q4 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Atara Biotherapeutics (ATRA) in Q4 2022, closing a stake of 12,737 shares — an estimated $1.2M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ATRA in Q2 2017 and held it in 22 quarters. The position peaked at $14.8M in Q1 2021. 138 funds tracked by Wall St. Rank hold ATRA as of Q4 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Atara Biotherapeutics position as of Q4 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 12,737 Atara Biotherapeutics shares in Q4 2022, an estimated $1.2M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Atara Biotherapeutics in Q2 2017 and held it in 22 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Atara Biotherapeutics position peaked at $14.8M in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2022, filed 14 Feb 2023.